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Abstract 56 
Background: Preventing recurrence of depression forms an important challenge for current 57 
treatments. Cognitive control impairments often remain present during remission of 58 
depression, putting remitted depressed patients at heightened risk for new depressive episodes 59 
by disrupting emotion regulation processes. Importantly, research indicates that cognitive 60 
control training targeting working memory functioning shows potential in reducing 61 
maladaptive emotion regulation and depressive symptomatology in clinically depressed 62 
patients and at-risk student samples. The current study aims to test the effectiveness of 63 
cognitive control training as a preventive intervention in a remitted depressed sample, 64 
exploring effects of cognitive control training on rumination and depressive symptomatology, 65 
along with indicators of adaptive emotion regulation and functioning. 66 
Methods/design: We present a double blind randomized controlled design. Remitted 67 
depressed adults will complete 10 online sessions of a cognitive control training targeting 68 
working memory functioning or a low cognitive load training (active control condition) over a 69 
period of 14 days. Effects of training on primary outcome measures of rumination and 70 
depressive symptomatology will be assessed pre-post training and at three months follow-up, 71 
along with secondary outcome measure adaptive emotion regulation. Long-term effects of 72 
cognitive control training on broader indicators of functioning will be assessed at three 73 
months follow-up (secondary outcome measures). 74 
Discussion: This study will provide information about the effectiveness of cognitive control 75 
training for remitted depressed adults in reducing vulnerability for depression. Furthermore, 76 
this study will address key questions concerning the mechanisms underlying the effects of 77 
cognitive control training, will take into account the subjective experience of the patients 78 
(including a self-report measure for cognitive functioning), and explore whether these effects 79 
extend to broad measures of functioning such as Quality of Life and disability. 80 
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Trial registration: This study is registered with ClinicalTrials.Gov, number NCT02407652. 81 
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Background 118 
Improving the effectiveness of psychotherapeutic interventions for depression forms an 119 
important challenge for depression research. That is,  patients who initially respond successful 120 
to therapy, often show residual symptoms which increases the chance of recurrence of 121 
depressive episodes. Moreover, existing treatments are less effective for chronic depression 122 
[1] and not all depressive symptoms show an equal response to treatment [2]. For instance, 123 
cognitive symptoms such as impaired executive- and working memory functioning and their 124 
biological substrates often remain present although the patient is considered to be in remission 125 
[e.g., 3, 4]. Importantly, it has been suggested that reduced cognitive functioning – i.e., 126 
impaired regulation of working memory, or ‘cognitive control’ – is not merely a byproduct of 127 
depression, but places remitted depressed (RMD) patients in a distinct vulnerable position for 128 
recurrence of depression [5, 6]. 129 
Indeed, the number of previous depressive episodes shows a negative correlation with 130 
behavioral indices of cognitive control [7]. Furthermore, prospective studies suggest that self-131 
reported cognitive control impairments [8] and their behavioral indices [9] predict the 132 
development of future depressive symptomatology. Interestingly, impaired cognitive control 133 
has typically been linked to maladaptive emotion regulation strategies such as rumination [9-134 
11], an important cognitive vulnerability factor for depression [12]. Especially brooding – a 135 
subtype of rumination that is characterized by a passive style of moody pondering – has 136 
shown to predict the occurrence of future depressive symptomatology [13]. Importantly, 137 
prospective studies indicate that the use of maladaptive emotion regulation strategies link 138 
impaired cognitive control to the development of future depressive symptomatology in RMD 139 
[14]. Thus, via maladaptive emotion regulation cognitive control impairments convey an 140 
important risk for recurrent depression [but see 15]. Moreover, this mechanism is believed to 141 
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sustain and increase biological and cognitive vulnerability for recurrent depression [for a 142 
review, see 6]. 143 
In accordance with studies indicating plasticity of executive and working memory 144 
functioning [16], these findings have led researchers to try to remediate cognitive control 145 
impairments in depression using cognitive training tasks. In a pilot study, Siegle et al. [17] 146 
demonstrated that combining treatment as usual (TAU) with a cognitive control training 147 
(CCT) shows potential in reducing rumination as well as depressive symptomatology in a 148 
limited MDD sample. The CCT existed of the adaptive Paced Auditory Serial Addition Task 149 
[PASAT; 18] and Well’s Attention training [19]. Furthermore, Siegle et al. [20] have 150 
extended these findings, showing long term beneficial effects of CCT by demonstrating a 151 
reduced need for outpatient services at one year follow-up. Interestingly, whereas previous 152 
studies have demonstrated the potential of a combined CCT approach [17, 20-22], other 153 
authors have shown that the training component targeting working memory functioning (the 154 
adaptive PASAT) might suffice to reduce brooding [23] and depressive symptomatology [24] 155 
in MDD patients. 156 
These first experimental findings are in line with existing conceptual frameworks 157 
concerning the role of cognitive control and rumination in recurrent depression [6, 25], 158 
suggesting that by remediating cognitive control impairments, one might decrease cognitive 159 
vulnerability for future depression. Accordingly, Siegle et al. [20] have suggested that effects 160 
of CCT on depressive symptomatology are preceded by changes in rumination. However, to 161 
date no experimental study has directly tested this mediation effect. Furthermore, previous 162 
studies have typically explored curative effects of CCT in MDD patients whereas only more 163 
recently the preventive potential of CCT has been explored in student populations. For 164 
instance, in a single session cognitive control manipulation, Cohen et al. [26] have 165 
demonstrated that inducing cognitive control while processing negative information buffers 166 
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against negative effects of a subsequent rumination induction procedure (i.e., state rumination, 167 
rumination-related sad mood). Moreover, training inhibition of emotional information has 168 
shown to reduce rumination in at-risk students [27]. Interestingly, researchers have found that 169 
the adaptive PASAT shows promise in reducing stress reactivity and rumination in response 170 
to a lab stressor directly following training and a naturalistic stressor at one month follow-up 171 
in an at-risk student sample [28]. Furthermore, decreased stress reactivity in confrontation 172 
with a lab stressor predicted lower brooding levels following confrontation with naturalistic 173 
stress (i.e., examination period). These findings suggest that CCT targeting working memory 174 
functioning shows potential as a preventive intervention for depression. 175 
Rational for the proposed study 176 
Previous studies indicate that the effects of CCT are not limited to the mere reduction of 177 
current depressive symptomatology in MDD patients, but might also extend to increasing 178 
resilience in at-risk populations. However, several theoretical gaps remain to be addressed.  179 
First, in order to fully explore the potential of CCT targeting working memory 180 
functioning in reducing (cognitive) vulnerability for depression, a test of training effects in a 181 
RMD sample would be desirable. That is, RMD patients form a high-risk group for 182 
developing future depressive episodes [29] and prospective studies indicate that impaired 183 
cognitive control forms an important vulnerability factor in RMD [14]. Second, from a 184 
theoretical stance it would be interesting to explore the proposed mediational pathway from 185 
effects of CCT on rumination to reduced future depressive symptomatology. Third, with the 186 
exception of Siegle et al. [20] who explored effects of CCT on outpatient service use, 187 
previous studies have limited their scope to exploring effects of CCT on rumination and 188 
depressive symptomatology. We aim at extending previous findings by also exploring effects 189 
of CCT on adaptive emotion regulation as well as broader indicators of (dis-)functioning such 190 
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as experienced disability, experienced remission from depression, and Quality of Life. 191 
Furthermore, we are not only interested in change in behavior indices of cognitive control, but 192 
also in the clinical experience of RMD patients concerning these cognitive factors (e.g., self-193 
report measures of executive- and working memory functioning). Finally, in order to reduce 194 
sources of bias in exploring the potential of CCT as a preventive intervention, a rigid 195 
methodological approach – i.e., a double-blind randomized controlled trial (RCT) – is 196 
required. 197 
Method 198 
Design 199 
We present a 2 (Condition) x 3 (Time) double blind, randomized controlled design. 200 
Adult RMD participants will be randomly allocated to either an online CCT intervention 201 
targeting working memory functioning or a low cognitive load training (active control 202 
condition). Both groups will perform 10 online training sessions over a period of 14 days, 203 
flanked by pre- and post-training lab assessments. Participants will return to the lab for a final 204 
assessment at three months follow-up (see Figure 1 for an overview of the design). This study 205 
has been approved by the local ethical committee of the Faculty of Psychology and 206 
Educational Sciences of Ghent University and was registered with ClinicalTrials.gov, number 207 
NCT02407652. 208 
Participants  209 
Inclusion and exclusion criteria 210 
To be eligible for participation to this study, participants aged between 23 and 65 should 211 
report a history of depression (at least one prior depressive episode) and report stable (partial) 212 
remission (≥ 6 months). Consequently, participants should not meet criteria for a current 213 
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depressive episode before starting training as assessed by the Mini-International 214 
Neuropsychiatric Interview [MINI; 30]. However, they should meet the criteria for a previous 215 
episode. The depressive episode should not have occurred in the context of a bipolar disorder. 216 
Neither should the participant report a history of psychosis, excessive substance abuse, or 217 
report experiencing cognitive impairments due to brain injury. A history of other comorbid 218 
disorders is allowed – yet these should not lead to current impairments – in order to increase 219 
the clinical relevance and validity of our study. Therapeutic maintenance contact (with a 220 
frequency less than once per three weeks) and use of antidepressant medication is allowed and 221 
will be registered. Importantly, antidepressant medication should be kept at a constant level 222 
throughout the course of the study. 223 
Recruitment 224 
RMD participants will be recruited using advertisements in popular (online) magazines 225 
and newspapers as well as flyers that were placed in 106 local drugstores (Ghent area). 226 
Furthermore, drawing on an existing database, 23 potentially interested participants will be 227 
contacted based on their interest in a prior prospective study of our lab (at that point, all of 228 
these participants had given their permission to be re-contacted in case a related study was 229 
planned). After having expressed interest in this study (i.e., by phone or e-mail), participants 230 
will be contacted by phone to provide further information and to screen eligibility based on a 231 
selection of relevant questions of the MINI screening version. To screen whether participants 232 
show a history of depression, we will ask questions concerning current and previous 233 
depressive symptoms, and collect information concerning the amount of episodes and past as 234 
well as current treatment. Furthermore, we will check whether (professional or similar) 235 
activities were resumed following the last depressive episode. If the participant seems eligible 236 
and is interested in participating in the study, he or she will be invited to the lab for a 237 
structured clinical interview (MINI). In the lab, the MINI screening version will be used to 238 
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check for indicators of currently present comorbid disorders and – if this proves to be 239 
necessary – will be followed by the corresponding parts of the MINI interview to allow to 240 
control for presence of comorbid disorders. The parts related to MDD will be fully assessed to 241 
assure that participants do not meet the criteria for MDD before entering the study. Meeting 242 
eligibility criteria will allow the participant to enroll in the study, starting immediately with 243 
randomization over one of both conditions and the baseline assessment. 244 
Measures 245 
Primary outcome measures 246 
Rumination and depressive symptomatology form our primary outcome measures. 247 
Rumination will be assessed using the Ruminative Response Scale [RRS; 13, 31]. This 22-248 
item questionnaire provides a total rumination score (range: 22 – 88), as well as Brooding and 249 
Reflection subscale scores (range: 5 – 20). Brooding is characterized by a passive style of 250 
moody pondering and is the most maladaptive form of depressive rumination [13, 32]. 251 
Depressive symptomatology will be assessed using the 21-item (range: 0 – 63) Beck 252 
Depression Inventory [BDI-II; 33, 34]. Both primary outcome measures exhibit adequate 253 
psychometric properties [13, 33, 34]. 254 
Secondary outcome measures 255 
Adaptive emotion regulation and indicators of RMD functioning will be our secondary 256 
outcome measures. Adaptive emotion regulation will be assessed using the five adaptive 257 
subscales of the Cognitive Emotion Regulation Questionnaire [CERQ; 35]. The four less 258 
adaptive strategies (self-blame, rumination, catastrophizing, and blaming others) can be used 259 
as a second, alternative measure for maladaptive emotion regulation (range: 4 – 20). 260 
Functioning will be operationalized by indices of disability, quality of life, resilience, 261 
and remission from depression. Disability will be assessed using the self-report version of the 262 
World Health Organization Disability Assessment Schedule 2.0 [WHODAS 2.0; 36], 263 
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consisting of 36 items. This measure is based on the conceptual framework of the 264 
International Classification of Functioning (ICF) and provides indicators of overall 265 
functioning and six specific domains of functioning (Cognition, Mobility, Self-care, Getting 266 
along, Life activities, and Participation). Furthermore, the questionnaire provides an estimate 267 
of the amount of days in the past month during which the difficulties (a) were present, (b) 268 
prevented the participant from performing his/her daily activities or work, or (c) formed a 269 
source of reduced functioning. Quality of life will be assessed using the depression-specific 270 
34-item (range: 0 – 34) Quality of Life in Depression Scale [QLDS; 37, 38]. Resilience will 271 
be assessed using the Resilience Scale [RS; 39, 40]. We will use the 25-item version of the RS 272 
using four point Likert-scales (range: 25 – 100). Finally, self-reported remission from 273 
depression will be assessed using the 41-item Remission of Depression Questionnaire [RDQ; 274 
41, 42] for which a high score is indicative for more psychopathology (range: 0 – 82). 275 
Manipulation check, training process and  cognitive transfer measures 276 
As a manipulation check and process measure, training task performance will be 277 
assessed in both conditions using median inter stimulus interval (ISI) levels per training 278 
session. Furthermore, as a process measure of effects of completing an online training session, 279 
mood (‘energetic’, ‘tense’, ‘frustrated’, ‘sad’, ‘happy’) will be assessed using visual analogue 280 
scales (VAS; 1 – 100). The extent to which participants have experienced negative thoughts 281 
and stress throughout the training session will also be assessed using VAS, along with 282 
experienced task competence (‘During the task I felt as if I was doing great’). It has been 283 
suggested that training cognitive control in a frustrating task-context – and thus, eliciting low 284 
levels of negative affect while training – contributes to the beneficial effects of CCT [28]. 285 
These process measures allow to explore the mechanism underlying CCT. Furthermore, we 286 
will use the Credibility/Expectancy Questionnaire [CEQ; 43, 44] to check for baseline group 287 
differences in treatment credibility/expectancy and to check for successful blinding of 288 
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participants (post-training). Moreover, we will monitor intake of antidepressants and other 289 
forms of therapy as well as stressful life events that might influence our findings. For the 290 
latter, we will use the List of Threatening Experiences [LTE; 45, 46]. 291 
Close transfer to cognitive control will be assessed using the non-adaptive PASAT [18]. 292 
During this task, participants are presented with a practice phase consisting of 10 trials, 293 
followed by a test phase, consisting of three blocks with increasing difficulty (ISI block 1 = 294 
3000 ms; ISI block 2 = 2000 ms; ISI block 3 = 1500 ms), each containing 60 trials. 295 
Furthermore, we will include the Behavior Rating Inventory of Executive Function Adult 296 
version [BRIEF-A; 47] as a self-report measure to assess experienced cognitive control. This 297 
75-item self-report questionnaire provides several estimates of executive and working 298 
memory functioning (e.g., inhibition, shifting, emotional control, working memory). 299 
Interventions 300 
Participants will either be subjected to an online CCT targeting working memory 301 
functioning (the adaptive PASAT) or a closely matched low cognitive load training. This 302 
allows to rule out motivational aspects of performing an adaptive computer task online. The 303 
tasks will be presented in-browser, using a Millisecond software Web license. Both training 304 
groups will be asked to perform 10 sessions of 400 trials (which takes 20 min per session at 305 
an average inter stimulus interval (ISI) of 3000 ms), providing similar learning experiences in 306 
both conditions. Prior to training, both groups will receive oral and written psycho-education 307 
concerning cognitive control training [based on the protocol of 17] in order to enhance task 308 
engagement. This is important as previous work indicates that task engagement forms an 309 
important predictor of response to CCT [20]. Importantly, no explicit information will be 310 
given about the to be expected results. Furthermore, participants will receive an automated 311 
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text message on a daily basis to prevent attrition during the training period [using 312 
SurveySignal software; 48]. 313 
Cognitive control training condition  314 
We will use an adaptive version of the PASAT [17, 18] to train participants’ cognitive 315 
control in the CCT condition. Participants will be presented with a continuous stream of 316 
auditory digits (1 – 9) and are instructed to immediately respond to the sum of the last two 317 
heard digits by clicking the corresponding response buttons (1 – 18). The speed of number 318 
presentation is adapted based on participants’ performance in order to train cognitive control 319 
in a frustrating task context. Participants begin each session with a 3000 ms ISI, which is 320 
reduced by 100 ms following every four consecutive correct responses, increasing task 321 
difficulty. Following every four incorrect responses the ISI increases with 100 ms, reducing 322 
task difficulty. Throughout each session participants are presented with their current ISI and 323 
amount of consecutive correct and incorrect responses. Participants’ responses and response 324 
times are being measured. In line with previous training studies the median ISI per session 325 
will be used as an indicator of ones performance during the training sessions.  326 
Active control condition 327 
In the active control condition, participants will be presented with a low cognitive load 328 
version of the adaptive PASAT. This training task shows high resemblance to the adaptive 329 
PASAT concerning stimuli, responses, modification of task difficulty, and evaluation of 330 
session performance. However, in this low cognitive load version of the adaptive PASAT 331 
participants are instructed to immediately respond to the last heard digit instead of mentally 332 
manipulating the content in working memory (i.e., instead of responding to the sum of the last 333 
two heard digits as in the CCT condition). To better resemble the response options of the 334 
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adaptive PASAT, participants in the active control condition are presented auditory stimuli 335 
ranging from 1 – 18. 336 
Sample size 337 
We are the first to explore effects of CCT targeting working memory functioning in a 338 
RMD sample which makes it impossible to provide an exact estimate of effect size for the 339 
main outcome measure in this sample. However, previous work on MDD patients has yielded 340 
an effect size of ɳ² = .19 for brooding [20], whereas work with at-risk undergraduate students 341 
revealed an effect size of ɳ² = .11 in confrontation with naturalistic stress [28]. Given that this 342 
study will use an at-risk sample (RMD), we will base estimations of sample size on the latter 343 
effect size. In order to be able to detect a similar effect over two time points with α = .05 and 344 
1-β = .80, the total sample size should at least be 68 (n CCT = 34, n active control = 34). We 345 
will stop recruiting once 68 participants have entered the training phase. 346 
Randomization 347 
Upon entering the study, participants will receive a sealed envelope containing an 348 
exterior subject number that will be used for registration purposes during the assessment 349 
sessions in the lab (baseline, post-training, and follow-up). The envelope will contain a 350 
training manual, an URL that directs participants to the online training task, and a personal 351 
training task identification code that should be used while performing the ten online training 352 
sessions at home. Prior to the study, an independent researcher will randomly link the training 353 
task identification codes to the subject numbers that will be used in the lab using an 354 
automated randomization program (RandList; randomisation.eu). This researcher will prepare 355 
the envelopes and keep a list of the linked subject numbers and training session identification 356 
codes in a locked closet at the office and a copy at home for safe keeping. Based on the 357 
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training task identification codes, participants will either perform the CCT or low cognitive 358 
load training.  359 
Blinding 360 
We present a double blind RCT design. Prior to the randomization procedure, the 361 
independent researcher will reset the online training task so that even-numbered training task 362 
identification codes will redirect the participants to one condition (CCT or active control), 363 
whereas odd-numbered training task identification codes will redirect the participants to the 364 
other condition. The researchers of this study will not be aware of the training task 365 
identification codes (these are randomly generated and presented in a sealed envelope) or the 366 
link between even- or odd-numbered identification codes and training condition. Furthermore, 367 
participants will be instructed not to share details concerning the content of the training task 368 
or the personal training task identification code with the researchers.  369 
During data-analysis, the researchers will remain blind of training task condition by 370 
separating (a) analysis of training task performance and process measures (based on even- or 371 
odd-numbered training task identification codes) from (b) analysis of training effects on the 372 
outcome measures. Concerning the latter, the independent researcher will provide the 373 
researchers with a list grouping the subject numbers – used during the lab sessions – in two 374 
non-informative conditions following completion of data-collection. Importantly, at this point 375 
(lab) subject numbers will not be linked to the personal training task identification codes. This 376 
allows blind evaluation of training effects. The blinding will only be broken for the more 377 
explorative analyses linking training task process measures with the outcome measures. 378 
Furthermore, we will use the CEQ-data to check for successful blinding of participants. 379 
Analysis 380 
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In line with Consolidated Standards of Reporting Trials [CONSORT; 49], we will use 381 
intention-to-treat (ITT) analysis to test effects of CCT on primary and secondary measures 382 
post-training and at follow-up. Missing data will be handled using the Last-Observation-383 
Carried-Forward (LOCF) method. Effects of CCT will be tested using Repeated Measures, 384 
analysis of variance (ANOVA), or covariance (ANCOVA) with follow-up t-tests. Exploratory 385 
analysis will take into account potential moderators of training effects such as variability in 386 
baseline depressive symptomatology and cognitive control. ITT might not necessarily apply 387 
to the exploratory analyses such as analysis of process measures of training. As secondary 388 
analysis, we will also perform completers-only analyses. Explorative within-group mediation 389 
analysis will be performed using a stepwise regression approach [50] and the Preacher and 390 
Hayes [51] bootstrapping method. 391 
Procedure 392 
Eligibility will be assessed by a clinical psychologist. Participants will first undergo a 393 
telephone screening to assess eligibility (see Figure 1). Second, potential participants will be 394 
invited to the lab where eligibility will be further assessed using the MINI. After giving 395 
informed consent, eligible participants will be randomized and the baseline assessment will 396 
take place (see Table 1). At baseline (Time 1), the behavior measure for cognitive control will 397 
be completed followed by the self-report measure for cognitive control (BRIEF-A). Next, 398 
participants will complete the other self-report questionnaires (primary outcome measures: 399 
BDI-II, RRS; secondary outcome measures: CERQ, QLDS, WHODAS 2.0, RS, RDQ) and 400 
will receive psycho-education concerning cognitive training for depression and practical 401 
information about the intervention. Participants will be instructed to complete 10 training 402 
sessions during a period of 14 days following the baseline assessment and will be asked to 403 
perform only one session a day. At the end of the baseline assessment session, the CEQ will 404 
be administered and participants’ telephone number will be registered using SurveySignal 405 
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software. During the 14-days period of online training, participants will receive a daily 406 
automated text message reminding them to complete the training. Each training session will 407 
consist of 400 trials of the adaptive PASAT or a low cognitive load training and will include 408 
assessments of affect and worrying throughout and following training. Upon completing 409 
training, participants will return to the lab for the post-training assessment (Time 2) during 410 
which direct effects of CCT on cognitive control and the primary outcome measures and 411 
adaptive emotion regulation will be assessed. At the end of the post-training session the CEQ 412 
will be administered to rule out group differences in expectancy and credibility of the 413 
intervention. Finally, participants will return to the lab at three months follow-up (Time 3) 414 
during which long-term effects on cognitive control and the primary and secondary outcome 415 
measures (including indicators of functioning) will be assessed. At each time point we will 416 
assess stressful life events (LTE), intake of antidepressants and other forms of therapy. Upon 417 
completion of the follow-up assessment session, participants will receive reimbursement 418 
(€75) followed by a partial written and oral debriefing. Importantly, participants will only 419 
receive feedback concerning their condition following processing of the data of the total 420 
sample. If CCT shows to have beneficial effects in RMD, participants from the active control 421 
condition will be offered the chance to perform the CCT online. 422 
Discussion 423 
Prevention of recurrent depression is an important target for interventions. Previous 424 
findings indicate that CCT shows potential in reducing depressive symptomatology and 425 
rumination in MDD as well as cognitive vulnerability in at-risk undergraduate students. To 426 
test the potential of CCT as a preventive intervention for depression, the present study aims to 427 
test the effectiveness of CCT in a RMD sample. We will test whether CCT targeting working 428 
memory functioning – as compared to a low cognitive load training – can be used to reduce 429 
vulnerability for depression over a 3.5 months period. We hypothesize that CCT will have 430 
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beneficial effects on primary outcome measures depressive rumination (i.e., brooding) and 431 
depressive symptomatology and hope to see these findings extend to adaptive emotion 432 
regulation and long-term functioning (secondary outcome measures). 433 
This double blind RCT study forms a first test of the potential of CCT as a preventive 434 
intervention for depression in RMD. Furthermore, these findings will be informative to the 435 
literature as several exploratory questions will be addressed in order to further elucidate the 436 
role of cognitive control in vulnerability for depression. First, we will explore whether effects 437 
of CCT on depressive symptomatology are mediated by rumination. Second, we will explore 438 
whether effects of CCT extend to measures of adaptive emotion regulation and indices of 439 
functioning such as quality of life and disability. Third, in order to further elucidate the 440 
mechanisms involved during CCT, we could explore how process measures of CCT relate to 441 
effects of training. 442 
Overall, this study will further enhance the knowledge on the role of cognitive control 443 
in emotion regulation and vulnerability for depression. This study forms a first step in testing 444 
the effectiveness of CCT targeting working memory functioning as a preventive intervention 445 
for (recurrent) depression. If these first results show to be promising, future work should 446 
focus on replicating the effects of CCT and exploring how this preventive intervention could 447 
best be implemented. 448 
Trial status 449 
We are currently recruiting RMD patients for this study. The study entered the data 450 
collection phase in April 2015. 451 
 452 
 453 
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Table 1 
Schedule of measures 
Instrument Telephone 
screening 
Baseline Online 
training  
Post-training  
(2 weeks) 
Follow-up (3 
months) 
Inclusion criteria interview X     
MINI Screen and structured interview  X    
Process measures of affect during training   X   
Process measures of training task performance (ISI)   X   
Credibility and expectancy of treatment (CEQ)  X  X  
Stressful life events (LTE)  X  X X 
Self-reported use of antidepressants and other forms of 
therapy  
 X  X X 
Cognitive control (non-adaptive PASAT / transfer task)  X  X X 
Self-reported cognitive control (BRIEF-A)  X  X X 
Depressive symptomatology (BDI-II)  X  X X 
Depressive rumination (RRS)  X  X X 
Cognitive emotion regulation (CERQ)  X  X X 
Quality of Life (QLDS)  X   X 
Disability (WHODAS 2.0)  X   X 
Resilience (RS)  X   X 
Remission from depression (RDQ)  X   X 
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Figure 1. Study flowchart 
 
